相关实验视频

Updated: Apr 13, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

含有纳米载体的可电离性脂质,用于输送抗菌剂

Haitao Yu¹, Sampa Sarkar¹, Z L Shaw²

¹School of Science STEM College RMIT University Melbourne Victoria 3000 Australia.

|April 11, 2025

概括

这项研究开发了新的可电离性脂质纳米粒子 (LNP),用于输送抗生素Piperacillin (Pip). 这些先进的纳米载体增强了药物输送,并对抗抗菌素耐药性 (AMR).

科学领域:

纳米技术和材料科学材料科学
传染病与微生物学
药物输送系统药物输送系统

背景情况:

抗微生物耐药性 (AMR) 是一个关键的全球健康挑战,减少了传统抗生素对不断演变的细菌病原体,特别是阴性菌株的有效性.
现有的抗生素疗法与具有先进防御机制的细菌作斗争,需要创新的药物输送策略来恢复疗效.

研究的目的:

探索自我组装的电离性脂质纳米颗粒 (LNP) 的开发,以增强广泛抗生素Piperacillin (Pip) 的传递.
调查结合阴离子 (ALC-0315) 和阴离子 (油酸) 电离性脂质对LNP特性和抗菌活性的影响.
提供一种新的策略来定制LNP成分以克服抗菌素耐药性.

主要方法:

利用同步子小角度X射线散射和动态光散射来分析LNP中相过渡,pH响应和纳米结构.
在酸性条件下采用了2-(p-toluidino) -6-naphthalene硫酸试验来研究电离行为.
描述了具有不同电离性脂质组成的LNP的物理化学性质 (大小,纳米结构,表面电荷).

主要成果:

在LNPs中加入阴离子电离性脂质ALC-0315诱导了pH响应和中相过渡,适合酸性感染环境.
结合ALC-0315和离子油酸调节LNP的物理化学特性和协同增强的抗微生物功效.
开发的LNP证明了提高透性和与细菌膜的融合,从而提高了抗生素的疗效.

结论:

在LNP中量身定制可离子化脂质成分为先进的抗微生物药物输送提供了一个有前途的战略.
这种方法提高了Piperacillin的疗效,并为打击抗菌素耐药性提供了新的途径.
该研究提出了一种新的纳米载体系统,有可能解决全球AMR危机.

关键词:

抗微生物耐药性抗微生物耐药性电离性脂质是一种可离子化的脂质.脂质纳米颗粒的使用方法热的液晶液晶热的液晶皮佩拉西林 (Piperacillin) 是一种药物.

更多相关视频

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...